Open for feedback
Consultation on proposed guidelines on pre-implantation genetic testing for cases involving specialist disagreement
ACART is currently consulting on proposed guidelines for pre-implantation genetic testing (PGT) for cases where specialists disagree. PGT is a way of checking embryos created through in vitro fertilisation (IVF) for certain genetic or chromosome conditions (e.g. cystic fibrosis) before pregnancy begins. The consultation is for a five-week period until 26 October 2026.
Closed for feedback
Consultation on developing a specified prescription medicines list for designated paramedic prescribers
The Ministry of Health is inviting submissions on a proposed list of prescription medicines for designated paramedic prescribers. Designated prescribing authority is the legal framework...
Public consultation on the Mental Health and Wellbeing Strategy
This is where you can share your feedback on the draft Mental Health and Wellbeing Strategy. You can answer as many or as few questions as you like, save your progress, and come back later if needed....
Verification Pathway for New Medicine Applications
This consultation is primarily aimed at pharmaceutical companies seeking to submit applications to Medsafe for new medicines for consent by verification. Consent by verification is the application...
Consultation on proposed changes to the classification of vitamin D pursuant to the Medicines Regulations 1984
This consultation asks for feedback on a proposal to increase the amount of vitamin D that is permitted in a general sale medicine. Currently, general sale medicines can contain up to 25 micrograms...
Ngā Paerewa Health and Disability Services Standard consultation 2026
Ngā Paerewa Health and Disability Services Standard 2021 (Ngā Paerewa) came into effect in February 2022. Under the requirements of the Health and Disability Services (Safety) Act 2001 (the Act), a...
Proposed extension of the abbreviated procedure for new medicine applications and section 24(5)(a) notifications
This consultation is aimed at pharmaceutical companies seeking to submit abbreviated applications to Medsafe for regulatory approval of new medicine products or changed medicine notifications. ...